COVID-19-Induced Guillain-Barré Syndrome.

Brooks, Joseph E; Mix, Felicia M; Buck, Justin C; Walters, Reid A

Brooks, Joseph E; Mix, Felicia M; Buck, Justin C; Walters, Reid A.

Brooks JE; Physical Medicine and Rehabilitation, Genesis Health System, Davenport, USA.
Mix FM; Physical Medicine and Rehabilitation, Burrell College of Osteopathic Medicine, Las Cruces, USA.
Buck JC; Physical Medicine and Rehabilitation, Lincoln Memorial University-DeBusk College of Osteopathic Medicine, Harrogate, USA.
Walters RA; Physical Medicine and Rehabilitation, Olivet Nazarene University, Bourbonnais, USA.

Cureus ; 13(11): e19809, 2021 Nov.

Article in English | MEDLINE | ID: covidwho-1579880

ABSTRACT

ABSTRACT

This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AIDP). The patient underwent intravenous immune globulin (IVIG) treatment and four weeks of acute inpatient rehabilitation with some functional improvement but remained unable to ambulate independently at discharge.

Keywords

covid 19; covid induced guillian barre syndrome; electrodiagnostic study; electromyography and electro-stimulation; guillain-barre syndrome (gbs)

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Cureus Year: 2021 Document Type: Article Affiliation country: Cureus.19809

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google